eric K. Frey, MBA, MS.T.C
Evan skowronski, ph.d
Chief Scientific Officer & Co-founder
Evan is responsible for optimization of the scientific and medical requirements. As microbiologist, has spent 22+ years directing optimization of scientific & technical requirements while working in technical roles for academic, government and private enterprises. As Division Chief of Biosciences at the Edgewood Chemical Biological Center, overseeing a staff of 100 scientists with a $40M budget. As Senior Biological Scientist at Lawrence Livermore National Laboratory, he served as the Sequencing Manager of the DOE genomics laboratory and later as assay development lead. He was a co-winner of the R&D100 award for the development of the deployable surveillance laboratory. Dr. Skowronski has a particular interest in the impact of oxygen on infection. He earned a B.S in Chemistry from Duke University (1990) and a Ph.D. in Molecular/Microbiology from Loma Linda University (1995).
Dr. Babak Ziaie, Ph.D
Chief Technology Officer
Babak is the Inventor of the patented oxygen generation and microfluidic delivery technology. He has been at Purdue University since Jan 2005. Dr. Ziaie is the recipient of the NSF Career award in Biomedical Engineering (2001) and McKnight Endowment Fund Award for Technological Innovations in Neuroscience (2002). At the Ziaie Biomedical Microdevices Laboratory (ZMBL) his research interests include; Biomedical micro/nano systems, solid-state microsensors, microactuators, MEMS packaging technology for implantable microsystems, drug delivery microsystems, biomedical microtelemetry, and advanced microinstrumentation techniques for high precision biological measurements. Babak received his PhD in Electrical Engineering at the University of Michigan in 1994.
MANNY OCHOA, PDF
VP of Engineering
Co-inventor of the technology. He completed his PhD at Purdue in 2016 and has been conducting a post-doctoral fellowship to advance the engineering of the technology through R&D, manufacturing process design and product testing. His research investigates the integration of common materials for the development low-cost, multifunctional platforms for medical applications, particularly for transdermal drug delivery and the treatment of chronic wounds.